1 new0 added2 reduced79 sold outnet sold ≈ $740.7m (-87.1m shares)
* Summed across managers. Shares that two managers' reports both contain – a
subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are
counted once.
Holder counts are more reliable.
Implied quarter-end price ≈ $8.30.
Trends to Q2 2024
Institutional holders
Managers reporting a position, each quarter
Numbers
Quarter
Holders
Q3 2022
155
Q4 2022
140
Q1 2023
125
Q2 2023
119
Q3 2023
110
Q4 2023
92
Q1 2024
83
Q2 2024
5
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D
if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the
stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder
worked them out.
Holder
Stake
Change
Shares
Last filed
Adiumentum Capital Fund I LP
13D · may seek influencefiled 2025-05-16Stated purposeItem 4 of the Initial 13D is hereby amended and supplemented to add the following information:
On May 14, 2025, Adiumentum agreed to purchase from the Issuer in connection with a registered offering (the "Registered Offering") an aggregate of (i) 75,572 shares (the "Shares") of the Issuer's common stock, par value $0.0001 per share (the "Common Stock"), and (ii) pre-funded warrants (each, a "Pre-Funded Warrant", and together, the "Pre-Funded Warrants") to purchase up to 227,000 shares of Common Stock, at a purchase price of $6.61 per share of Common Stock and $6.6099 per share of Common Stock issuable upon exercise of the Pre-Funded Warrants. The exercise price of each Pre-Funded Warrant is equal to $0.0001 per share, subject to adjustment as provided therein, and the Pre-Funded Warrants …
Full filing